Article info
Myopathies
Novel myosin-based therapies for congenital cardiac and skeletal myopathies
- Correspondence to Julien Ochala, Centre of Human & Aerospace Physiological Sciences, Faculty of Life Sciences and Medicine, King's College London, Room 3.3, Shepherd's House, Guy's Campus, London SE1 1UL, UK; julien.ochala{at}kcl.ac.uk
Citation
Novel myosin-based therapies for congenital cardiac and skeletal myopathies
Publication history
- Received April 29, 2016
- Accepted June 15, 2016
- First published July 13, 2016.
Online issue publication
September 22, 2016
Article Versions
- Previous version (22 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/